Study Shows Vision, Anatomy Stable With Port System for AMD

Recalled in 2022, a port delivery system for ranibizumab to treat wet AMD demonstrated that vision and retinal anatomy remained stable in patients who had the device for 5 years.

Related Keywords

Iowa , United States , Texas , American , David Massop , Genentech Roche , Charles Wykoff , American Society Of Retina Specialists , Novartis , Regeneron Pharmaceuticals , Drug Administration , Blanton Eye Institute , Wolfe Eye Clinic , Des Moines , American Society , Retina Specialists , Medscape Medical , Age Related Macular Degeneration Treatments Trial , Retina Consultants , Houston Methodist Hospital , Presented July , Retinal Disease , Exudative Age Related Macular Degeneration , Xudative Armd , Anatomy , Vision Care And Maintenance , Retina , Ophthalmologic Trauma , Phthalmologic Injuries , Ocular Injury , Eye Injuries , Eye , Vitreous Hemorrhage , Itreous Bleeding , Hyphema , Macular Degeneration , Ge Related Macular Degeneration Armd , Sclera , Visual Acuity , Vitreous , Patient Safety , Rhegmatogenous Retinal Detachment , Cataracts , Heal ,